Infinium Pharmachem Limited (NSE:INFINIUM)
India · Delayed Price · Currency is INR 266.20
-7.80 (-2.85%)
Sep 11, 2026, 3:18 PM IST
Infinium Pharmachem Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 4,148 | 3,004 | 3,366 | 3,187 | - | - | |
Market Cap Growth | 3.88% | -10.75% | 5.63% | - | - | - |
Enterprise Value | 4,179 | 3,210 | 3,555 | 3,380 | - | - |
Last Close Price | 266.20 | 192.80 | 241.90 | 229.00 | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 34.14 | 24.73 | 41.33 | 28.20 | - | - |
PS Ratio | 2.19 | 1.58 | 2.16 | 2.35 | - | - |
PB Ratio | 3.00 | 2.17 | 2.70 | 5.29 | - | - |
P/TBV Ratio | 3.53 | 2.55 | 3.17 | 5.42 | - | - |
P/FCF Ratio | 17.25 | 12.49 | - | 226.68 | - | - |
P/OCF Ratio | 12.30 | 8.91 | - | 64.80 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.20 | 1.69 | 2.28 | 2.49 | - | - |
EV/EBITDA Ratio | 19.38 | 14.88 | 21.46 | 18.21 | - | - |
EV/EBIT Ratio | 22.58 | 17.35 | 26.79 | 21.27 | - | - |
EV/FCF Ratio | 17.38 | 13.35 | - | 240.40 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.11 | 0.11 | 0.34 | 0.06 | 1.23 | 1.62 |
Debt / EBITDA Ratio | 0.72 | 0.72 | 2.53 | 0.19 | 1.82 | 2.24 |
Debt / FCF Ratio | 0.64 | 0.64 | - | 2.45 | 26.03 | 3.19 |
Net Debt / Equity Ratio | -0.10 | -0.10 | 0.06 | -0.14 | 0.98 | 1.23 |
Net Debt / EBITDA Ratio | -0.66 | -0.66 | 0.42 | -0.46 | 1.45 | 1.70 |
Net Debt / FCF Ratio | -0.60 | -0.60 | -0.20 | -6.03 | 20.70 | 2.42 |
Asset Turnover | 1.02 | 1.02 | 1.10 | 1.74 | 1.76 | 2.21 |
Inventory Turnover | 2.83 | 2.83 | 2.61 | 4.15 | 3.95 | 5.79 |
Quick Ratio | 2.22 | 2.22 | 1.15 | 1.98 | 0.67 | 0.76 |
Current Ratio | 3.84 | 3.84 | 2.20 | 3.73 | 1.40 | 1.39 |
Return on Equity (ROE) | 10.79% | 10.79% | 8.48% | 27.38% | 52.08% | 63.77% |
Return on Assets (ROA) | 6.20% | 6.20% | 5.84% | 12.73% | 14.19% | 13.10% |
Return on Invested Capital (ROIC) | 11.87% | 11.51% | 9.80% | 24.32% | 28.59% | 30.82% |
Return on Capital Employed (ROCE) | 12.70% | 12.70% | 9.80% | 23.40% | 43.50% | 34.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 2.93% | 4.04% | 2.42% | 3.55% | - | - |
FCF Yield | 5.80% | 8.00% | -10.22% | 0.44% | - | - |
Buyback Yield / Dilution | -7.16% | -7.16% | -36.49% | -4.80% | - | - |